In silico drug repurposing approach for the discovery of therapeutics for intestinal fibrosis in crohn's disease

被引：0
|
作者：
Nikolakis, D. [1 ]
Yim, A. Y. F. Li [2 ]
Lartey, D. [3 ]
Rieder, F. [4 ]
D'Haens, G. R. [5 ]
van de Sande, M. G. H. [6 ]
Lowenberg, M. [5 ]
机构：
[1] Univ Amsterdam, Amsterdam Inst Gastroenterol Endocrinol & Metab, Amsterdam Inst Infect & Immun, Dept Gastroenterol & Hepatol,Amsterdam UMC,Dept Rh, Amsterdam, Netherlands
[2] Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Amsterdam UMC, Amsterdam, Netherlands
[3] Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Dept Gastroenterol, Amsterdam UMC, Amsterdam, Netherlands
[4] Cleveland Clin, Lerner Res Inst, Ctr Global Translat Inflammatory Bowel Dis Res, Dept Gastroenterol Hepatol & Nutr,Digest Dis Inst,, Cleveland, OH USA
[5] Univ Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam UMC, Amsterdam, Netherlands
[6] Univ Amsterdam, Amsterdam Inst Infect & Immun, Dept Rheumatol & Clin Immunol, Dept Expt Immunol,Amsterdam UMC, Amsterdam, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0346
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0172
引用
收藏
页码：i570 / i571
页数：2
相关论文
共 50 条
  • [1] Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach
    Marak, Brilliant N.
    Dowarah, Jayanta
    Khiangte, Laldingluaia
    Singh, Ved Prakash
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (03) : 374 - 392
  • [2] Drug repurposing: a better approach for infectious disease drug discovery?
    Law, G. Lynn
    Tisoncik-Go, Jennifer
    Korthl, Marcus J.
    Katze, Michael G.
    CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (05) : 588 - 592
  • [3] The immunological landscape of intestinal fibrosis in Crohn's Disease
    Jacobs, I.
    Creyns, B.
    Dragoni, G.
    Cremer, J.
    Bislenghi, G.
    D'Hoore, A.
    Ke, B. J.
    Matteoli, G.
    De Hertogh, G.
    Ferrante, M.
    Joao, G. S.
    Breynaert, C.
    Vermeire, S.
    Verstockt, B.
    Vanuytsel, T.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S168 - S169
  • [4] In-silico repurposing of antiviral compounds against Marburg virus: a computational drug discovery approach
    Rahul Kumar Singh
    Kaushik Sarkar
    Rajesh Kumar Das
    In Silico Pharmacology, 13 (1)
  • [5] The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn's Disease
    Zhang, B. I. N.
    Zhang, Shuixing
    GASTROENTEROLOGY, 2021, 161 (06) : 2065 - 2066
  • [6] Current Topics of the Mechanism of Intestinal Fibrosis in Crohn's Disease
    Honzawa, Yusuke
    Yamamoto, Shuji
    Okabe, Makoto
    Seno, Hiroshi
    Nakase, Hiroshi
    IMMUNO, 2021, 1 (04): : 574 - 582
  • [7] The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn's Disease
    Hayashi, Yuki
    Nakase, Hiroshi
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [8] Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease
    Watanabe, Daisuke
    Kamada, Nobuhiko
    FRONTIERS IN MEDICINE, 2022, 9
  • [9] Intestinal Fibrosis in Crohn's Disease: Medical Treatment or Surgery?
    Spinelli, Antonino
    Correale, Carmen
    Szabo, Hajnalka
    Montorsi, Marco
    CURRENT DRUG TARGETS, 2010, 11 (02) : 242 - 248
  • [10] Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer?s disease
    Neha, Suhel Parvez
    AGEING RESEARCH REVIEWS, 2023, 85
12345